semaglutide liver fat reduction CDSCO Clears Wegovy for MASH — India's First GLP-1 Approval for Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on Why are GLP-1 agonists being

A 15-amino-acid peptide based on a sequence from a protein found in the stomach Studied in rat research for its effects on the healing of tendon, muscle and gut tissue Investigated in cell and animal studies for its effects on blood-vessel growth and the nitric oxide pathway Studied for how it interacts with the body's own protective (prostaglandin) system For research use only

When the body loses fat, the veins may become more visible

Thus, CHAC1s upregulation enhances the survival and aggressiveness of cancer cells in the tumor microenvironment, leading to a poor prognosis (Parande et al., 2024)

PlexusDx's 503A partners follow the United States Pharmacopeia (USP) standards for potency, purity, and sterility

The Ethics of Ozempic and Wegovy

GHK-Cu combined with tretinoin, estriol, and niacinamide